Net clinical benefit of edoxaban versus no treatment in a ‘real world’ atrial fibrillation population: a modelling analysis based on a nationwide cohort study

Andrew D. Blann, Amitava Banerjee, Deirdre A. Lane, Christian Torp-pedersen, Gregory Y.h. Lip

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)
323 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Net clinical benefit of edoxaban versus no treatment in a ‘real world’ atrial fibrillation population: a modelling analysis based on a nationwide cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences